MACROGENICS INC

Nasdaq:MGNX

Pharmaceutical Preparations·Rockville, MD

CEO

Risser Eric Blasius

CFO

Karrels James

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/9/26	→
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/5/24	→
↓

Earnings Releases (8-K)

28 shown

Filed	Period
3/9/26	Q1 FY2026	→
11/12/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/20/25	Q1 FY2025	→
11/5/24	Q4 FY2024	→
↓

News (8-K)

52 shown

Filed	Type	Description
3/2/26	Other	Other Events	→
2/24/26	Other	Other Events	→
11/20/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/13/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/10/25	Agreement	Entry into a Material Definitive Agreement	→
5/22/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/14/25	S-8	S-8	→
5/23/24	S-8	S-8	→
4/8/24	ARS	ARS	→
11/6/23	S-3	S-3	→
6/6/23	S-8	S-8	→
4/17/23	ARS	2022 ANN REPORT TO SHAREHOLDERS	→
↓

Filing History(894 filings)

TypeDateAccessionPeriodSize

8-K

Mar 9, 2026

0001125345-26-0000188-K

Mar 9, 2026

409.3 KB

10-K

Mar 9, 2026

0001125345-26-00001710-K

Dec 31, 2025

11.5 MB

8-K

Mar 2, 2026

0001125345-26-0000118-K

Mar 2, 2026

134.1 KB

8-K

Feb 24, 2026

0001125345-26-0000098-K

Feb 23, 2026

345.9 KB

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001246

—

10.1 KB

Feb 17, 2026

0001588365-26-000005FORM 4

Feb 12, 2026

12.4 KB

Feb 17, 2026

0002051299-26-000005FORM 4

Feb 12, 2026

12.3 KB

Feb 17, 2026

0001587477-26-000005FORM 4

Feb 12, 2026

12.5 KB

Feb 17, 2026

0001706903-26-000004FORM 4

Feb 12, 2026

12.4 KB

Feb 17, 2026

0001675464-26-000004FORM 4

Feb 12, 2026

12.4 KB

Feb 17, 2026

0001587774-26-000004FORM 4

Feb 12, 2026

12.4 KB

Feb 17, 2026

0001587514-26-000007FORM 4

Feb 15, 2026

6.8 KB

SCHEDULE 13G/A

Feb 13, 2026

0001231919-26-000143

—

29.5 KB

Feb 10, 2026

0001587514-26-000004FORM 4

Feb 8, 2026

6.7 KB

Feb 10, 2026

0001675464-26-000002FORM 4

Feb 7, 2026

12.8 KB

Feb 10, 2026

0002051299-26-000002FORM 4

Feb 7, 2026

12.7 KB

Feb 10, 2026

0001587774-26-000002FORM 4

Feb 7, 2026

12.8 KB

Feb 10, 2026

0001706903-26-000002FORM 4

Feb 7, 2026

12.8 KB

Feb 10, 2026

0001587477-26-000002FORM 4

Feb 7, 2026

13.0 KB

Feb 10, 2026

0001588365-26-000002FORM 4

Feb 7, 2026

12.8 KB

SCHEDULE 13G/A

Jan 6, 2026

0001104659-26-001469

—

9.1 KB

Dec 10, 2025

0002051299-25-000004FORM 4

Dec 8, 2025

5.2 KB

8-K

Nov 20, 2025

0001125345-25-0001118-K

Nov 14, 2025

136.4 KB

8-K

Nov 12, 2025

0001125345-25-0001098-K

Nov 12, 2025

430.4 KB

10-Q

Nov 12, 2025

0001125345-25-00010810-Q

Sep 30, 2025

5.3 MB

25 filings shown

Filed	Form	Description
4/11/25	DEFA14A	DEFA14A	→
4/11/25	DEF 14A	DEF 14A	→
4/8/24	DEFA14A	DEFA14A	→
4/8/24	DEF 14A	DEF 14A	→
4/19/23	DEFA14A	DEFA14A	→
4/17/23	DEFA14A	DEFA14A	→
↓

MACROGENICS INC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(894 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/17/26	4	4	→
2/17/26	4	4	→
2/17/26	4	4	→
2/17/26	4	4	→
2/17/26	4	4	→
2/17/26	4	4	→
↓